clonazepam has been researched along with dantrolene in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benfenati, F; Bonanno, G; Giovedì, S; Raiteri, L; Raiteri, M | 1 |
| Kahlert, S; Martínez-Sánchez, M; Reiser, G; Reymann, KG; Schröder, UH; Striggow, F | 1 |
| Chang, Y; Lin, YW; Wang, SJ | 1 |
| Chou, SH; Chou, SS; Huang, RF; Huang, SK; Kuo, YC; Leu, CY; Liew, YF; Lin, TY; Lu, CW; Tzeng, WF; Wang, SJ | 1 |
| Chang, Y; Huang, SK; Wang, SJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for clonazepam and dantrolene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for clonazepam and dantrolene
| Article | Year |
|---|---|
Cellular mechanisms of the acute increase of glutamate release induced by nerve growth factor in rat cerebral cortex.
Topics: Animals; Animals, Newborn; Anticoagulants; Benzylamines; Blotting, Western; Caffeine; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Central Nervous System Stimulants; Cerebral Cortex; Clonazepam; Dantrolene; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Fura-2; Glutamic Acid; Heparin; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Mitogen-Activated Protein Kinase Kinases; Muscle Relaxants, Central; Nerve Growth Factor; Peptide Fragments; Phosphoprotein Phosphatases; Phosphorylation; Potassium; Proto-Oncogenes; Rats; Rats, Sprague-Dawley; Receptor, trkA; Sulfonamides; Synapsins; Synaptosomes; Thiazepines | 2003 |
Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Boron Compounds; Calcium; Calcium Channel Blockers; Cell Death; Clonazepam; Dantrolene; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fura-2; Glucose; Hippocampus; Hypoxia; In Situ Nick-End Labeling; Indoles; Intracellular Space; Ion Exchange; Lidocaine; Mibefradil; Nimodipine; Organ Culture Techniques; Quinoxalines; Rats; Rats, Wistar; Sodium; Sodium Channel Blockers; Thiazepines; Thiourea; Time Factors | 2004 |
Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A.
Topics: 4-Aminopyridine; Animals; Aspartic Acid; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Carbazoles; Cerebral Cortex; Clonazepam; Cyclic AMP-Dependent Protein Kinases; Dantrolene; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Indoles; Isoquinolines; Macrolides; Male; Maleimides; Membrane Potentials; Nerve Endings; omega-Conotoxins; Potassium; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; Sulfonamides; Synaptosomes; Thiazepines; Ubiquinone | 2011 |
HTDP-2, a new synthetic compound, inhibits glutamate release through reduction of voltage-dependent Ca²⁺ influx in rat cerebral cortex nerve terminals.
Topics: 4-Aminopyridine; Amino Acid Transport System X-AG; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cerebral Cortex; Clonazepam; Cytosol; Dantrolene; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Glutamic Acid; Male; Membrane Potentials; Nerve Endings; Neuroprotective Agents; Potassium Channel Blockers; Pyridones; Rats; Rats, Sprague-Dawley; Sodium Potassium Chloride Symporter Inhibitors; Synaptosomes; Thiazepines; Tosyl Compounds | 2011 |
Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
Topics: 4-Aminopyridine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cerebral Cortex; Clonazepam; Dantrolene; Glutamic Acid; Macrolides; Male; MAP Kinase Signaling System; Membrane Potentials; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Nerve Endings; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Synapsins; Synaptosomes; Thiazepines; Ubiquinone | 2012 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |